D&D Pharmatech

디앤디파마텍 · 347850

Industrials Commercial Services · KOSDAQ

Large-cap

Market cap US$2.7B (₩3.7T)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$3.1M

▼ −62.4% YoY

Operating profit · FY2025

−US$24.6M

Loss widened

Net income · FY2025

−US$17.4M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2024	FY2025
Revenue	US$8.3M(₩11.4B)	US$3.1M(₩4.3B)
Operating profit	−US$18.1M(−₩25B)	−US$24.6M(−₩34B)
Net income	−US$21.4M(−₩29.5B)	−US$17.4M(−₩24B)

Revenue

Operating profit

Net income

ROE

-30.4%

Debt/Eq

23.5%

Op. margin

-791.0%

Net margin

-558.0%

Rev. YoY

▼ −62.4%

Interactive price history isn't here yet. Would you use it?